Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2022

Nov 10, 2022

29750_dirs_2022-11-10_9fd2705d-f9ce-4503-a260-8bd4665ad62c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2022-11-09

Reporting Person: Wengel Kathryn E (EVP, Chief GSC Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-09 Common Stock M 16410.0000 $72.5400 Acquired 87720.8735 Direct
2022-11-09 Common Stock S 16410.0000 $173.4170 Disposed 71310.8735 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-11-09 Employee Stock Options (Right to Buy) $72.5400 M 16410.0000 Disposed 2023-01-13 Common Stock (16410.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 52.0000 Indirect
Common Stock 281.0000 Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $173.41 to $173.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2022).

F3: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2022).